UW Medicine

Seattle Times Features the Dog Aging Project

Tags: Dog aging project, General Press,

HALo’s Dog Aging Project—which hopes to develop treatments to slow aging and provide dogs and cats with three to five or more years of additional healthy, youthful life—was featured on the Cover of today’s Seattle Times with the article “UW scientists seek to extend dogs’ lives with anti-aging drug​”  The Seattle Times article describes the second part of the project […]

Read More…

Fountain Of Puppyhood: Can New Drug Lengthen Your Dog’s Life?

Tags: Dog aging project, General Press,

WBUR’s the Wild Life featured an article, “Fountain of puppyhood: can new drug lengthen your dog’s life?” on HALo’s Dog Aging Project. The Dog Aging Project strives to develop treatments to slow aging and offer longer, healthier life in people and their pets.  The article references UW scientist’s research on rapamycin as well as WebMB, […]

Read More…

Dog Aging Project Featured in Nature

Tags: Dog aging project, Scientific Press,

HALo’s Dog Aging Project—which hopes to develop treatments to slow aging and provide dogs and cats with three to five or more years of additional healthy, youthful life—was featured in an October 29th Nature article “Pet dogs set to test anti-ageing drug”.  Low doses of rapamycin have been shown to safely slow aging and extend the period of […]

Read More…

The Healthspan Imperative

Tags: Healthspan, Why basic biology of aging,

The Alliance for Aging Research—the leading non-profit organization dedicated to accelerating the pace of scientific discoveries to improve the experience of aging—has launched the “Healthspan Campaign” with this great video which explains the urgent need for aging research. Find out more about the Alliance Find out more about the Healthspan Campaign […]

Read More…

HALo Director, Matt Kaeberlein, Featured in UW Medicine Magazine

Tags: Faculty, General Press,

The Spring 2014 cover story of UW Medicine magazine, “Exploring Why We Age”, features the work of UW Healthy Aging and Longevity Research Institute Director, Matt Kaeberlein, Ph.D.  Decades of wear and tear — that’s the age-old explanation for common afflictions of aging: creaking joints, wrinkling skin, weakening muscles, slowing mental processes. Over millennia, people […]

Read More…

Treatments to rejuvenate the aging heart?

Tags: Heart failure, Scientific Press,

Caloric restriction is an anti-aging strategy that has been shown to extend lifespan and improve age-related diseases in animal models including non-human primates. Rapamycin, an FDA approved immune-suppressant drug, shares some similar anti-aging effects as caloric restriction.  However, most studies of the anti-aging effects of caloric restriction or Rapamycin have been long-term studies in which […]

Read More…

Curing a Childhood Syndrome? Kaeberlein Lab discovers possible drug for Leigh syndrome.

Tags: Leigh syndrome, Scientific Press,

While investigating the role of rapamycin (an FDA-approved immune-suppressant drug) in aging of yeast, fruit flies and C. elegans, researchers in Matt Kaeberlein’s lab also discovered something else. The drug can extend lifespan and alleviate neurological symptoms in a mouse model of mitochondrial disease. Mitochondria are a cells’ power generators, and mitochondrial dysfunction can lead […]

Read More…

Improving muscle function: Effects of age may be more reversible than previously thought

Tags: Muscle function, Scientific Press,

The loss of skeletal muscle function is a leading cause of frailty and loss of independence in the elderly, which comes along with significant healthcare costs.  Mitochondrial dysfunction plays a key pathogenic role in aging skeletal muscle, but currently there is no pharmacologic treatment to rapidly reverse mitochondrial deficits in the elderly. David Marcinek’s lab […]

Read More…

Anti-oxidant compound protects against heart failure in mice

Tags: Heart failure, Scientific Press,

A recent study in the Rabinovitch Lab has shown that an anti-oxidant compound, called SS-31, effectively protects against heart failure in mice, demonstrating a potential therapeutic value for human heart diseases. The study, Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides, was published in the September 2013 issue of Circulation: […]

Read More…

Dr. Daniel Promislow joins the Healthy Aging and Longevity Research Institute

Tags: Faculty,

We are delighted to announce that Dr. Daniel Promislow has joined the core HALo Faculty at the University of Washington. Dr. Promislow has worked for over 25 years on the biology of aging, and brings to UW his expertise in quantitative genetics, biodemography, and comparative systems and theoretical biology in aging research. Starting out at […]

Read More…